ACS

Latest Features

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Benefits of Inpatient Smoking Cessation Therapy Post-Myocardial Infarction

Hospitals may be missing opportunities to start tobacco use treatment immediately after myocardial infarction.

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives

An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

Assessing Chest Pain in ER With Short-term Risk Stratification Tool

The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Oxygen Therapy for Acute MI: Best Practice or Harmful Treatment?

Evidence is lacking to support oxygen therapy for acute myocardial infarction.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Room for Improvement: Pharmacologic Management of Acute Coronary Syndromes

Poor adherence to dual antiplatelet therapy plays a significant role in outcomes for patients with acute coronary syndromes.

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

Risk of Cardiovascular Disease Questioned in Testosterone Therapy Use

The American Association of Clinical Endocrinologists site lack of evidence of cardiovascular disease risk in testosterone therapy use.

Latest News

Oxygen Therapy in Acute MI Not Associated With Clinical Benefit

Oxygen Therapy in Acute MI Not Associated With Clinical Benefit

Patients with confirmed or suspected acute myocardial infarction do not benefit from supplemental oxygen therapy.

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Women are less likely than men to fill a high-intensity statin prescription following hospitalization for myocardial infarction.

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Although varenicline was effective for short-term smoking cessation, more than half of the patients in the EVITA trial relapsed after 1 year.

Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain

Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain

Two analyses were conducted, one during the training phase and the second during the validation phase of the study.

Strongest Predictors of STEMI Adverse Outcomes in Cardiogenic Shock

Strongest Predictors of STEMI Adverse Outcomes in Cardiogenic Shock

Time from first medical contact to primary percutaneous coronary intervention is inversely linked to short-term survival in STEMI.

Acute MI With Diabetes Mortality Predicted by Acute-to-Chronic Glycemic Ratio

Acute MI With Diabetes Mortality Predicted by Acute-to-Chronic Glycemic Ratio

In patients with diabetes who had an acute myocardial infarction, the acute-to-chronic glycemic ratio was a better predictor of mortality compared with baseline glycemia levels.

Clopidogrel Tablets Recalled Due to Mislabeling

Clopidogrel Tablets Recalled Due to Mislabeling

One lot of clopidogrel, a platelet inhibitor, has been recalled due to mislabeling.

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.

ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management

ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management

The American College of Cardiology and the American Heart Association have released updated quality and performance measures for STEMI and NSTEMI management.